{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:45:18Z","timestamp":1774521918073,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005624","name":"Hannover Medical School","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005624","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hookipa Biotech"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["WI 3308\/3-1"],"award-info":[{"award-number":["WI 3308\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"crossref","award":["111150"],"award-info":[{"award-number":["111150"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ymthe.2017.07.012","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T05:48:14Z","timestamp":1500529694000},"page":"2533-2545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Recombinant LCMV Vectors Induce Protective Immunity following Homologous and Heterologous Vaccinations"],"prefix":"10.1016","volume":"25","author":[{"given":"Jessica","family":"Wingerath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitrij","family":"Ostroumov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman","family":"Woller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel D.","family":"Pinschewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Orlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Berka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"K\u00fchnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.07.012_bib1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3770","article-title":"Going viral with cancer immunotherapy","volume":"14","author":"Lichty","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2017.07.012_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.immuni.2010.10.004","article-title":"Immunologic basis of vaccine vectors","volume":"33","author":"Liu","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2017.07.012_bib3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/biot.201400390","article-title":"Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials","volume":"10","author":"Kallel","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ymthe.2017.07.012_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1586\/erv.13.34","article-title":"Live-attenuated Listeria-based immunotherapy","volume":"12","author":"Rothman","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ymthe.2017.07.012_bib5","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.4049\/jimmunol.1000751","article-title":"Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA\/MVA vaccine","volume":"185","author":"Kannanganat","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2017.07.012_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.07.012_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nm.2104","article-title":"Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T\u00a0cell immunity","volume":"16","author":"Flatz","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2017.07.012_bib8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1099\/vir.0.051102-0","article-title":"Arenavirus reverse genetics for vaccine development","volume":"94","author":"Ortiz-Ria\u00f1o","year":"2013","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.ymthe.2017.07.012_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/pathogens4020283","article-title":"Human hemorrhagic fever causing arenaviruses: molecular mechanisms contributing to virus virulence and disease pathogenesis","volume":"4","author":"Shao","year":"2015","journal-title":"Pathogens"},{"key":"10.1016\/j.ymthe.2017.07.012_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.immuni.2010.06.014","article-title":"Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T\u00a0cell differentiation","volume":"33","author":"Wirth","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2017.07.012_bib11","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.4049\/jimmunol.0902874","article-title":"Tracking the total CD8 T\u00a0cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts","volume":"183","author":"Rai","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2017.07.012_bib12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/ni1098","article-title":"CD8+ T\u00a0cell contraction is controlled by early inflammation","volume":"5","author":"Badovinac","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2017.07.012_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1074-7613(00)80147-8","article-title":"Attrition of T\u00a0cell memory: selective loss of LCMV epitope-specific memory CD8 T\u00a0cells following infections with heterologous viruses","volume":"11","author":"Selin","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2017.07.012_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nature07486","article-title":"Memory CD8 T-cell compartment grows in size with immunological experience","volume":"457","author":"Vezys","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.07.012_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CMR.0b013e328353e65c","article-title":"Ipilimumab in advanced melanoma: reports of long-lasting responses","volume":"22","author":"Farolfi","year":"2012","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ymthe.2017.07.012_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.07.012_bib17","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2017.07.012_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.07.012_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.07.012_bib20","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.vaccine.2012.02.016","article-title":"Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination","volume":"30","author":"Verheust","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2017.07.012_bib21","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.2174\/092986711796957211","article-title":"The \u201cSTEP-wise\u201d future of adenovirus-based HIV vaccines","volume":"18","author":"Patterson","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ymthe.2017.07.012_bib22","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1128\/JVI.01459-06","article-title":"Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought","volume":"81","author":"Masopust","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2017.07.012_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2017.07.012_bib24","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.290.5495.1354","article-title":"Regulation of antigen-specific CD8+ T\u00a0cell homeostasis by perforin and interferon-gamma","volume":"290","author":"Badovinac","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.07.012_bib25","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A\u00a0simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.07.012_bib26","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.154.9.4414","article-title":"Antigen processing in\u00a0vivo and the elicitation of primary CTL responses","volume":"154","author":"Restifo","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2017.07.012_bib27","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.4049\/jimmunol.173.9.5679","article-title":"Duration of infection and antigen display have minimal influence on the kinetics of the CD4+ T\u00a0cell response to Listeria monocytogenes infection","volume":"173","author":"Corbin","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2017.07.012_bib28","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.4049\/jimmunol.166.5.3402","article-title":"Organ-specific regulation of the CD8 T\u00a0cell response to Listeria monocytogenes infection","volume":"166","author":"Pope","year":"2001","journal-title":"J.\u00a0Immunol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617303283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617303283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T16:17:33Z","timestamp":1692893853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617303283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1525001617303283"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.07.012","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant LCMV Vectors Induce Protective Immunity following Homologous and Heterologous Vaccinations","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}